81806-213-13 : NDC 2026 Code

81806-213-13 : Deflazacort ( Jaythari Oral Suspension )

Additionally :

You can get information about “81806-213-13” NDC code in 81806-213-13 in HTML format

HTML | 81806-213-13 in TXT (Plain Text) format

TXT | 81806-213-13 in PDF (Portable Document Format)

PDF | 81806-213-13 in XML format

XML formats.

NDC Code : 81806-213-13 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "81806-213-13",
    "PackageDescription": "1 BOTTLE in 1 CARTON (81806-213-13)  / 13 mL in 1 BOTTLE",
    "NDC11Code": "81806-0213-13",
    "ProductNDC": "81806-213",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Jaythari Oral Suspension",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Deflazacort",
    "DosageFormName": "SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20251120",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA220042",
    "LabelerName": "Doppel Farmaceutici S.r.l.",
    "SubstanceName": "DEFLAZACORT",
    "StrengthNumber": "22.75",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-09-12",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20251120",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}